Since compounds 4 and 6–8 exhibited significant inhibitory activities against α-glucosidase and PTP1B (which play important enzymes in therapeutic strategy against DM), four candidates were subjected to a molecular docking analysis. Here, PTPN1 is linked to diabetes mellitus.